chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: TDAP
Symptoms: Sleep disorder, Vaccination site nodule, Vaccination site pain
Clinical narrative: I woke up the morning of the 12th with a knot of soreness in the left upper arm at the site of my tetanus vaccination. Since then I have developed extreme soreness in my arm, shoulder blade, and neck. I have reduced range of motion in my left arm. I have intermittent burning pain radiating up my arm to my neck. NSAIDs, Tylenol, warming pads, and sore muscle creams do not adequately dampen the pain. The pain is so intense and that it often keeps me up at night. I will have to have a follow up appointment as the pain seems to be intensifying.
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site warmth
Clinical narrative: Patient was given FLUZONE HIGH-DOSE 2016-17 on 01/26/2017. Patient come back to the pharmacy 01/28/2017. The area around the injection site is red and very warm to the touch. The red area is approx. 6 inches in length and 3-4 inches in width. The injection site is very tender to the touch and there is a lump at the injection site.  Patient said that when given the shot it hurt immediately.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Rash around injection site.
Age: 90.0
Sex: M
Vaccine: DTP
Symptoms: Injection site swelling
Clinical narrative: Patient developed localized swelling at injection site but no other adverse symptoms. Cold pack was applied to site for 10-15 minutes with swelling diminishing.
Age: 90.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Syringe issue
Clinical narrative: Patient came in for FLUZONE HIGH DOSE on Saturday. Upon injection, I noticed there was a lot of resistance and it felt like nothing was going in, so I removed the syringe. While examining the syringe, I push down on the plunger harder and a lot of the medication came out. I did not readminister using the same syringe because the patient would not have gotten the proper dose. I prepared another one and injected him. This time it went smoothly. Spoke with patient on Sunday and he said he was fine and had no reaction.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Eye irritation, Oral discomfort, Oral pruritus, Pruritus
Clinical narrative: The area around my mouth began to burn and itch. My eyes began burning. Then my face from the bridge of my nose into my neck became red and itchy. I took BENADRYL which helped but the burning and itching keeps coming back.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Abasia, Computerised tomogram, Electroencephalogram, Injection site pain, Laboratory test
Clinical narrative: Unresponsive for 1.5 hours, leg pain, refusal to walk.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Unresponsive to stimuli
Clinical narrative: Unresponsive for 1.5 hours, leg pain, refusal to walk.
Age: 83.0
Sex: M
Vaccine: PPV
Symptoms: Cerebrovascular accident, Vaccination complication
Clinical narrative: CVA, reaction to PNEUMOVAX (L) arm, happened same day.
Age: 48.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Pyrexia
Clinical narrative: Got body aches, undocumented fever the night of vaccine which lasted 8 hrs.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Peripheral swelling, Skin warm
Clinical narrative: Left arm swollen below elbow heat, called Dr. advised to put ice packs and monitor.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Hypoaesthesia
Clinical narrative: Patient noticed 3 areas of bruises on her lower administrating arm. She also complained of numbness on her right hand.
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Left deltoid pain since administer date 10/24/16. No fever.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Right posterior deltoid pain and swelling, redness, feverishness mild headache.
Age: 71.0
Sex: F
Vaccine: PNC13
Symptoms: Burning sensation, Pruritus, Rash
Clinical narrative: Rash (R) upper arm, itching w/burning sensation.
Age: 1.0
Sex: F
Vaccine: HEPA, MMRV, VARCEL
Symptoms: Extra dose administered, Wrong drug administered
Clinical narrative: Pt in our office on 1/23/17 inadvertently given MMRV instead of MMR. Also given dose of VARIVAX.
Age: 57.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: Erythema, softball size swelling, warmth. Treatment: Diphenhydramine MG, methylprednisolone.
Age: 1.33
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema
Clinical narrative: A very large area of erythema surrounding the injection site appeared and progressed to approximately 1 1/2" - 2". On 3rd day started improving. This is the second strong reaction to DTaP from same Lot in 2-3 weeks.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: No adverse reaction noted Pt received a Hep B at birth 9/7/16. Pt received PEDARIX on 11/11/16. He was administered PEDARIX on 1/25/17. Hep B should have not be given until 3/3/17.
Age: 77.0
Sex: M
Vaccine: PNC13
Symptoms: Rash
Clinical narrative: Skin rash.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMRV, VARCEL
Symptoms: Injection site rash
Clinical narrative: Rash on left arm, resolved following day after vaccination 1/25/2017
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: 8 inch, indurated, swollen, erythematous area surrounding MMR injection site (3 days prior). No treatment necessary.
Age: 1.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Pyrexia, Viral rash
Clinical narrative: Patient was seen 1/13/17 for 12mth WCC and also received vaccinations. Seen 1/23/17 for viral exam then from possible MMR received 10 days prior to visit w/o fever and rash at that visit.
Age: 3.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, PNC13
Symptoms: Expired product administered, No adverse event
Clinical narrative: Dtap vaccine - administered expired vaccine exp. date 12-3-16. No adverse reactions.
Age: 39.0
Sex: F
Vaccine: YF
Symptoms: Dyspnoea, Oropharyngeal swelling, Periorbital oedema, Urticaria
Clinical narrative: Oral hives and anterior chest hives 45 min after injection. Spread to include periorbital edema. Self-administered famotidine, SOLU-MEDROL and BENADRYL with some relief. To ER for further evaluation. Developed shortness of breath and posterior oropharyngeal swelling. BENADRYL 50m and epinephrine administered with significant improvement. Sent home with prednisone, famotidine and EPI-PEN.
Age: 52.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Hypoaesthesia, Injection site nodule, Paraesthesia
Clinical narrative: 1/19/17: Woke to knot between armpit and injection site. Numbness and tingling down her left all the way to toes. PCP diagnosed as delayed systemic reaction. Medicated with steroid shot and BENADRYL.
Age: 52.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Arthralgia, Burning sensation, Drooling, Dysarthria, Injection site pain
Clinical narrative: 1/19/17: Woke to knot between armpit and injection site. Numbness and tingling down her left all the way to toes. PCP diagnosed as delayed systemic reaction. Medicated with steroid shot and BENADRYL.
Age: 52.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Nuclear magnetic resonance imaging, Pain in extremity, Urticaria
Clinical narrative: 1/19/17: Woke to knot between armpit and injection site. Numbness and tingling down her left all the way to toes. PCP diagnosed as delayed systemic reaction. Medicated with steroid shot and BENADRYL.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site vesicles
Clinical narrative: Shot given 1-4-17. Patient came into pharmacy 1/10/2017. Presented with what looked like a broken blister at injection site. It is red, size of a nickel and stated it burns. Told him to not cover with bandaid any more.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Blood glucose normal, Pallor, Presyncope, Syncope, Tremor
Clinical narrative: 1/20/2017: 16:50, HPV #3 was administered to deltoid while pt. was sitting on exam table. She bent over after vax was given. She was pale and fainted for a few seconds. Had mild trembling for a few seconds as she recovered. Back to baseline within a few minutes. Vital signs and pulse ox normal. Was observed for greater than one hour and D/C to home. Suspect vasovagal reaction to vaccine. No complications. Did not need any intervention except close observation.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Lymphadenopathy
Clinical narrative: Pt. received vaccine on 1/15/17 at 3 pm. Pt. called 1/16/17 at 12 pm stating swollen glands - pt was advised to take BENADRYL. Around 1 pm, pt. was contacted stated going to urgent care. Tried following up with patient the next day, no response.
Age: 11.0
Sex: M
Vaccine: FLU4, HPV9, MNQ, TDAP, FLU4, HPV9, MNQ, TDAP
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 1.33
Sex: F
Vaccine: DTAP, FLU4, HIBV
Symptoms: Febrile convulsion, Skin warm, Tremor
Clinical narrative: 1/28/17 early AM-Dad awoke to patient shaking (lasting approx 15 seconds) and felt hot to touch. The shaking stopped for a few minutes and started back for approx. 15 seconds. EMS notified. Hospital diagnosed patient with a simple febrile seizure.
Age: 51.0
Sex: M
Vaccine: FLU4
Symptoms: Influenza
Clinical narrative: Patient was given a flu vaccine. Pt had the influenza virus.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort, Pain
Clinical narrative: Patient describes pain/discomfort (sometimes a sharp pain) when moving her right arm in certain ways. When raising arm above her head, try to push or pull or bear weight with that arm. States pain is worse the more active she is. Will see MD for evaluation 1/31/17.
Age: 50.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Asthenia, Mobility decreased, Musculoskeletal pain
Clinical narrative: Shoulder pain, loss of strength, and movement, shot was given on 11-2-2016, symptoms on 11-3-2016. Severe pain-treatment-home therapy, anti-inflammatory and pain pills.
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Pt C/O some soreness at vac site on 1/24/17 PM. Soreness at site continued but pt. wasn't aware of 8 1/2 cm x 8 cm redness surrounding vac site until 1/26/17 AM. Vac site was also warm to touch. Pt. to apply ice and use TYLENOL p.r.n.
Age: 64.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Pain in extremity, Pyrexia, Rash pruritic
Clinical narrative: Fever, rash itchy, arm pain and redness.
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, HPV9, MNQ
Symptoms: Erythema, Injection site swelling, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: Arm swelling, double in size from shoulder/injection site to fingers. Red, warm, hives in palm, occurred a few hours after vaccine administered, lasted 7 days.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Body temperature increased, Cold sweat, Dizziness, Erythema, Feeling abnormal
Clinical narrative: Student immunized at 09:15 TDaP, MCV4, HPV. At 09:30 student returned to class at 10:05. Teacher called asking for assistance student pale, C/O dizziness, hand clammy to touch, eyes droopy. BP 112/80 awake looked sleepy, daze. Ammonia inhaler x1 used. Student reposition flat on her back feet elevated. Respirations 18 pulse 60. Redness hives presented to face at 10:19am. Diphenhydramine 50 mg given IM to Left deltoid. Temp 99.6 degrees F pulse 99 O2 Sat 94%. At 11:30am student mother picked her up. Student will resolved rash and no distress verbalized. Not: Returned to school the next day. Student reported she felt like fainting on her mensus and was feeling anxious about receiving vaccine all day.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Pallor, Somnolence, Urticaria
Clinical narrative: Student immunized at 09:15 TDaP, MCV4, HPV. At 09:30 student returned to class at 10:05. Teacher called asking for assistance student pale, C/O dizziness, hand clammy to touch, eyes droopy. BP 112/80 awake looked sleepy, daze. Ammonia inhaler x1 used. Student reposition flat on her back feet elevated. Respirations 18 pulse 60. Redness hives presented to face at 10:19am. Diphenhydramine 50 mg given IM to Left deltoid. Temp 99.6 degrees F pulse 99 O2 Sat 94%. At 11:30am student mother picked her up. Student will resolved rash and no distress verbalized. Not: Returned to school the next day. Student reported she felt like fainting on her mensus and was feeling anxious about receiving vaccine all day.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: The patient called the pharmacy approximately 4 hours after vaccination to report pain, redness, and swelling in the arm. She was instructed to use an ice pack.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV1
Symptoms: Diarrhoea
Clinical narrative: Explosive diarrhea for days following vaccines. Went to ER and was just advised to follow up w/PCP. All SX's resolved on their own within 1 week.
Age: 7.0
Sex: F
Vaccine: IPV
Symptoms: Pyrexia
Clinical narrative: Fever 101-102 effect after.
Age: 76.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Pain, Swelling
Clinical narrative: 1/24; evening sore 1/25; sore, swollen, red-patchy (2"x3") 1/28; normal 1/30; follow-up - recovering.
Age: 53.0
Sex: F
Vaccine: FLUC3
Symptoms: Injection site haematoma, Injection site nodule, Ultrasound scan abnormal
Clinical narrative: Case number PHHY2015US051011, is a spontaneous report initially received from a healthcare professional via the Vaccine Adverse Event Reporting System (VAERS reference number: 568670) website on 21 Apr 2015. This report refers to a 53-year-old female patient. Historical conditions included lipoma and bumps. She was vaccinated with FLUCELVAX (batch number 161211) in the left arm on 02 Dec 2014. On the same day, she had a little knot at the injection site deltoid which remained for a couple of days and then went down. It came back and has persisted since then. It was reported that she had such bumps before but they have always gone in few days. She went to emergency room. An ultrasound of the deltoid was ordered to confirm that the lesion was indeed hematoma. Outcome of the events was reported as condition unchanged. The events were reported as non-serious. The causality of the events was not reported. Following an internal review on 12 May 2015 of the report received on 21 Apr 2015, the event hematoma was recoded as Vaccination site hematoma and the event skin lesion was deleted. Follow up received via the Vaccine Adverse Event Reporting System website on 24 Nov 2015: Suspect product was recoded as FLUCELVAX.
Age: 2.0
Sex: F
Vaccine: FLUX
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Case number PHHY2015US162806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 574695) website on 24 Nov 2015. This report refers to a 02-year-old female patient. Historical condition included, patient was wheezing with illness and born at 30 weeks gestation. Concomitant medication was not reported. The patient who was 02 years old was inadvertently vaccinated with 02 doses of influenza vaccine (manufacturer unknown and batch number: not reported) last year on an unknown date. No adverse event was reported following this medication error.
Age: 48.0
Sex: F
Vaccine: FLUX
Symptoms: Vaccination complication
Clinical narrative: Case number PHHY2015US162827, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 575690) website on 24 Nov 2015. This report refers to a 48-year-old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) in Oct 2014. After vaccination, the patient experienced severe adverse reaction to a flu vaccine. The outcome, seriousness and causality of the event were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2015US162787, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 577683) website on 24 Nov 2015. This report refers to an elderly female patient of unknown age. Past medical history and concomitant medications were not reported. Prior vaccination history included first dose of influenza vaccine on an unknown date and included swelling, pain, warmth and redness at injection site. The patient was vaccinated with a second dose of seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on an unknown date. On an unknown date, the patient experienced injection site swelling, injection site warmth, injection site erythema and injection site pain. The physician divided the second flu shot into one fifth of actual dose so that the patient would try and mitigate any reaction to the shot. The outcome of the events was unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following an internal review for the data received on MRD 24 Nov 2015 significant case correction was done: The events injection site pain, swelling, erythema and warmth were re-coded with vaccination site pain, swelling, erythema and warmth.
Sex: U
Vaccine: FLUX
Symptoms: Gluten sensitivity
Clinical narrative: Case number PHHY2015US156545, is a spontaneous report initially received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 588333) website on 24 Nov 2015. This report refers to a patient of an unknown age and gender. Medical history and concomitant medications were unknown. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unknown date after vaccination the patient was diagnosed with gluten intolerance. Outcome of the event was unknown. The case was assessed as non-serious. Causality of the event was not reported.
Sex: U
Vaccine: FLUX
Symptoms: Gluten sensitivity
Clinical narrative: Case number PHHY2015US159171, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 588352) website on 24 Nov 2015. This report refers to a patient of unknown demographics. Medical history was not reported. The patient was on no other medications. Vaccination history included administration of influenza vaccine (manufacturer and batch number: not reported). The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unknown date after vaccination the patient experienced gluten intolerance. Outcome of the event was unknown. The case was assessed as non-serious. Causality of the event was not reported.
Sex: M
Vaccine: FLUX, HEPA
Symptoms: Abnormal behaviour, Asocial behaviour, Drug administered to patient of inappropriate age, Pyrexia, Wrong drug administered
Clinical narrative: Case number PHHY2015US157913, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 594770) website on 02 Nov 2015. This report refers to a 1.7 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with second dose of seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on 11 Sep 2015. The patient was vaccinated with first dose of Hepatitis A vaccine (manufacturer unknown and batch number: not reported) on 11 Sep 2015. On 11 Sep 2015, the patient was given INFs pres free 3 years adult influenza vaccine while he was supposed to get INFs pres free 6-35 month influenza vaccine. On 23 Sep 2015, the patient started acting very differently than before such as losing social skills and self stimming and the doctor reported that the nurse gave the wrong influenza vaccine. The patient was experienced fever on an unknown date. The outcome of the events was not reported. The seriousness of the event fever was not reported and for others events it was reported as non serious and by the health authority. The causality of the events was not reported.
Age: 19.0
Sex: M
Vaccine: FLUX, MEN
Symptoms: Culture throat, Headache, Injection site erythema, Injection site pain, Lymphadenopathy
Clinical narrative: Case number PHHY2015US157785, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 594905) website on 02 Nov 20515. This report refers to a 19 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine and Meningococcal B vaccine (manufacturer unknown and batch number: not reported) on 08 Sep 2015. On the 08 Sep 2015, the patient experienced severe headache, body aches, fever 102 (units unspecified), red and tender (L) deltoid 12x7 cm size, sore throat and swollen tender glands in sup cervical areas. It was reported that, rapid streptococcus test was negative and throat culture test was pending. The outcome of the events was not reported. The seriousness of the events was reported as non serious by the health authority. The causality of the events was not reported.
Age: 19.0
Sex: M
Vaccine: FLUX, MEN
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Streptococcus test negative, Tenderness
Clinical narrative: Case number PHHY2015US157785, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 594905) website on 02 Nov 20515. This report refers to a 19 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine and Meningococcal B vaccine (manufacturer unknown and batch number: not reported) on 08 Sep 2015. On the 08 Sep 2015, the patient experienced severe headache, body aches, fever 102 (units unspecified), red and tender (L) deltoid 12x7 cm size, sore throat and swollen tender glands in sup cervical areas. It was reported that, rapid streptococcus test was negative and throat culture test was pending. The outcome of the events was not reported. The seriousness of the events was reported as non serious by the health authority. The causality of the events was not reported.
Age: 79.0
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Erythema, Headache, Mobility decreased, Pain in extremity, Somnolence
Clinical narrative: Case number PHHY2015US157815, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 595020) website on 02 Nov 2015. This report refers to a 79 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and PREVNAR 13 vaccine (batch number: not reported) on 27 Aug 2015. On 28 Aug 2015, the patient experienced arm sore and red (reported as spot size of tennis ball) for approximately 10 days, first few days could not raise the arm above shoulder, for first 24 hours experienced headache and felt sleepy. The patient applied ice to the arm. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious by the health authority. The causality of the events was not reported.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site nodule
Clinical narrative: Case number PHHY2015US157863, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 595049) website on 02 Nov 2015. This report refers to a 35 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) intramuscularly on 09 Sep 2015. On 10 Sep 2015, the patient experienced raised knot type area near injection site. The outcome of the event was unknown. The seriousness of the event was reported as non serious by the health authority. The causality of the event was not reported.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Mobility decreased, Nodule, Pain
Clinical narrative: Case number PHHY2015US157220, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 595871) website on 24 Nov 2015. This report refers to a 34-year-old female patient. Medical history was not reported. The patient had no current illness. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) into the left arm on 15 Sep 2015. On 16 Sep 2015, the patient experienced pain, cannot lift the arm and developed knot underarm. Final outcome of the events was unknown. Events were reported as non-serious. Causality was not reported.
Age: 51.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Chest pain, Erythema, Impaired work ability, Injection site erythema, Migraine
Clinical narrative: Case number PHHY2015US156028, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 596254) website on 24 Nov 2015. This report refers to a 51 years old female patient. Past medical history included asthma, ulcer and chronic obstructive pulmonary disease (COPD). Concomitant medications included ARMOUR THYROID. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and pneumococcal vaccine (manufacturer unknown and batch number: not reported) on 16 Sep 2015. On the same day after vaccination, the patient experienced redness, pain, fever, nausea, muscle aches, pain, cramping, rash, severe migraine, redness and swelling at vaccine site, severe pain on chest on same sife of vaccine/chest pain 5 if not moving, cannot move arm without severe pain, migraine scale over 10. The patient missed 2 entire days of work and not recovered from pain, redness, swelling, rash. Outcome of the migraine was reported as condition unchanged and outcome of other events was not reported. Seriousness of the events was reported as non serious and causality of the events was not reported.
Age: 51.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Muscle spasms, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Case number PHHY2015US156028, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 596254) website on 24 Nov 2015. This report refers to a 51 years old female patient. Past medical history included asthma, ulcer and chronic obstructive pulmonary disease (COPD). Concomitant medications included ARMOUR THYROID. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and pneumococcal vaccine (manufacturer unknown and batch number: not reported) on 16 Sep 2015. On the same day after vaccination, the patient experienced redness, pain, fever, nausea, muscle aches, pain, cramping, rash, severe migraine, redness and swelling at vaccine site, severe pain on chest on same sife of vaccine/chest pain 5 if not moving, cannot move arm without severe pain, migraine scale over 10. The patient missed 2 entire days of work and not recovered from pain, redness, swelling, rash. Outcome of the migraine was reported as condition unchanged and outcome of other events was not reported. Seriousness of the events was reported as non serious and causality of the events was not reported.
Age: 51.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Rash, Vaccination site swelling
Clinical narrative: Case number PHHY2015US156028, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 596254) website on 24 Nov 2015. This report refers to a 51 years old female patient. Past medical history included asthma, ulcer and chronic obstructive pulmonary disease (COPD). Concomitant medications included ARMOUR THYROID. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and pneumococcal vaccine (manufacturer unknown and batch number: not reported) on 16 Sep 2015. On the same day after vaccination, the patient experienced redness, pain, fever, nausea, muscle aches, pain, cramping, rash, severe migraine, redness and swelling at vaccine site, severe pain on chest on same sife of vaccine/chest pain 5 if not moving, cannot move arm without severe pain, migraine scale over 10. The patient missed 2 entire days of work and not recovered from pain, redness, swelling, rash. Outcome of the migraine was reported as condition unchanged and outcome of other events was not reported. Seriousness of the events was reported as non serious and causality of the events was not reported.
Sex: M
Vaccine: FLUX, PPV, VARZOS
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2015US173781, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 596371) website on 29 Dec 2015. This report refers to a male patient of an unknown age. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) along with ZOSTAVAX (batch number: not reported) and PNEUMOVAX 23 (batch number: not reported) on 15 Aug 2015. In Aug 2015, the patient experienced a fever of 102 degrees within 24 hours of receiving vaccinations. The patient took MOTRIN and rested at home as treatment. Final outcome of the event was recovered. Event was reported as non-serious. Causality was not reported.
Sex: F
Vaccine: FLUX, HEP, HEPA
Symptoms: Visual field defect, Visual impairment
Clinical narrative: Case number PHHY2015US156596, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 596780) on 24 Nov 2015. This report refers to a 43 years old female patient. Historical condition included hypothyroid. Concomitant medication included levothyroxine (manufacture unknown). The patient received seasonal influenza vaccine (manufacture unknown, batch number, expiry date: not reported) along with Hepatitis A and Hepatitis B (other manufacture, batch number, expiry date: not reported) on 21 Sep 2015. On the same date after vaccination, patient experienced visual disturbance as kaleidoscope vision outside area of focus, strobe effect in peripheral vision. The seriousness of the events were reported as non serious. The outcome of the events was reported as complete recovery. The causality of the events was not reported.
Age: 27.0
Sex: F
Vaccine: FLUX
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Pain, Pharyngeal hypoaesthesia
Clinical narrative: Case number PHHY2015US155774, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 596786) website on 24 Nov 2015. This report refers to a 27 years old female patient. Historical condition included PCOS (polycystic ovarian syndrome). Patient had no current illness. Concomitant medication included ADVIL migraine for migraine. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on right arm on 21 Sep 2015. On the same day after vaccination, the patient's vaccination site arm became numb, the numbness spread to the whole right side of body within an hour, including neck, ear, cheek, as well as her side, breast, leg and foot and during the remainder of the day, the numbness would came in waves, followed  by sharp pains on the right side of body, the numbness would spread further during each wave and eventually made her tongue and throat numb and paresthesia. The patient was visited to emergency room. The outcome of the events was reported as unknown. The seriousness of the event was reported as non serious and causality not reported.
Sex: M
Vaccine: FLUX, PNC13
Symptoms: Musculoskeletal pain, Neck pain, Pain in extremity
Clinical narrative: Case number PHHY2015US159936, is an initial spontaneous report received from a consumer (patient's spouse) via Vaccine Adverse Event Reporting System (VAERS reference number: 596917) website on 24 Nov 2015. This report refers to a 74 years old male patient. Medical history and concomitant medications were unknown. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) and PREVNAR 13 (batch number: not reported, other manufacturer) on 03 Nov 2014. On 07 Nov 2014 the patient experienced arm, shoulder and neck pain. Outcome of the events was improving. The case was assessed as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Musculoskeletal disorder, Pain in extremity
Clinical narrative: Case number PHHY2015US160287, is an initial spontaneous report received from a pharmacist via Vaccine Adverse Event Reporting System (VAERS reference number: 596965) website on 24 Nov 2015. This report refers to a female patient of an unknown age. Medical history was not reported. The patient was on no other medications. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported, site of vaccination not reported) along with PREVNAR 13 (batch number: not reported, site of vaccination not reported) on an unspecified date (reported as about a month before). On an unknown date in 2014, the patient experienced a lot of pain in the arm to the point that the patient could not use the arm. Final outcome of the events was not recovered. Events were reported as non-serious. Causality was not reported.
Age: 70.0
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Blood culture positive, Chest discomfort, Chest pain, Headache, Oropharyngeal pain
Clinical narrative: Case number PHHY2015US157347, is an initial spontaneous report from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 596967) received on 24 Nov 2015. This report refers to a 70-year-old female patient. Past medical history included body myositis, Addison's disease and immune system disease. Past medications included LYRICA, CELEBREX and other unspecified fourteen medications. The patient experienced unspecified events while she was on LYRICA, CELEBREX and unspecified fourteen medications. Concomitant medication included prednisone (manufacturer unknown) at low dose. The patient was vaccinated with Seasonal influenza vaccine (manufacturer and batch number: not reported) and PREVNAR 13 (batch number: not reported) both received on 03 Nov 2014. The patient reported that on 07 Nov 2014 she started feeling bad in chest, throat and head with pain down in her chest. Her pain medications were not helping her with headache. On her throat, she had white patches, red streaks and swelling and she had pain all time. She went to the physician who told the patient that it was not a streptococcal throat infection, rather she had a viral infection and symptoms were not related to the vaccinations she received. On an unknown date in Nov2014 streptococcal throat test and blood culture viral test were performed and results came as negative for streptococcal throat test and positive for blood culture viral test. The patient wanted to know if PREVNAR 13 could have caused a viral infection. Outcome of the events was reported as worsened at the time of this report. Seriousness and causality of the events were not reported. The patient did not want to provide any more information and she stated she did not want to get her doctor into any trouble. No follow up attempts possible. No further information expected.
Age: 70.0
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Pharyngeal erythema, Pharyngeal oedema, Streptococcus test negative, Viral infection
Clinical narrative: Case number PHHY2015US157347, is an initial spontaneous report from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 596967) received on 24 Nov 2015. This report refers to a 70-year-old female patient. Past medical history included body myositis, Addison's disease and immune system disease. Past medications included LYRICA, CELEBREX and other unspecified fourteen medications. The patient experienced unspecified events while she was on LYRICA, CELEBREX and unspecified fourteen medications. Concomitant medication included prednisone (manufacturer unknown) at low dose. The patient was vaccinated with Seasonal influenza vaccine (manufacturer and batch number: not reported) and PREVNAR 13 (batch number: not reported) both received on 03 Nov 2014. The patient reported that on 07 Nov 2014 she started feeling bad in chest, throat and head with pain down in her chest. Her pain medications were not helping her with headache. On her throat, she had white patches, red streaks and swelling and she had pain all time. She went to the physician who told the patient that it was not a streptococcal throat infection, rather she had a viral infection and symptoms were not related to the vaccinations she received. On an unknown date in Nov2014 streptococcal throat test and blood culture viral test were performed and results came as negative for streptococcal throat test and positive for blood culture viral test. The patient wanted to know if PREVNAR 13 could have caused a viral infection. Outcome of the events was reported as worsened at the time of this report. Seriousness and causality of the events were not reported. The patient did not want to provide any more information and she stated she did not want to get her doctor into any trouble. No follow up attempts possible. No further information expected.
Age: 65.0
Sex: M
Vaccine: FLUX, PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2015US160019, is an initial spontaneous report received from consumer (patient's wife) via Vaccine Adverse Event Reporting System (VAERS reference number: 596981) website on 24 Nov 2015. This report refers to a 65-year-old-male patient. Historical condition was not reported. Current conditions included pain, nerves pains, depression, anxiety, cholesterol and stomach function disorder. Concomitant medication included tramadol (manufacturer unknown), Trazodone (manufacturer unknown), methadone (manufacturer unknown), omeprazole (manufacturer unknown), clonazepam (manufacturer unknown), hydrocodone (manufacturer unknown), Vitamin C supplement, Vitamin D, vitamins (rainbow light), oral gemfibrozil (manufacturer unknown). The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and PREVNAR 13 (batch number: not reported) in to left arm intramuscularly on 29 Jan 2015. On 30 Jan 2015 after vaccination, the patient experienced left upper arm red, hot and swollen and it hurt him really bad for 2 days/ Reporter had put a line around the red swollen area to see if it was going to spread. The patient was getting better at time of this reported. The outcome of the events was reported as condition improving. Serious and causality of the events was not reported.
Age: 36.0
Sex: F
Vaccine: FLUX
Symptoms: Contusion, Local swelling, Skin warm, Tenderness
Clinical narrative: Case number PHHY2015US159093, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 597022) website on 24 Nov 2015. This report refers to a 36-year-old female patient. The patient had no medical history and current illness. Concomitant medication included lamotrigine. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported, site of vaccination not reported) on 21 Sep 2015. On the same day after vaccination the patient experienced palm sized swelling, hot raised, tender and bruised etc (not further specified). Final outcome of the events was unknown. Events were reported as non-serious. Causality was not reported.
Age: 45.0
Sex: F
Vaccine: FLUX
Symptoms: Back pain, Dysstasia, Gait disturbance, Muscle tightness
Clinical narrative: Case number PHHY2015US158045, is an initial spontaneous report received from Vaccine Adverse Event Reporting System, (VAERS reference number: 597035) website on 24 Nov 2015. This report refers to a 45-year-old male patient. Past medical history was not reported. Current conditions included type 2 diabetes and high blood pressure. Concomitant medication included: montelukast sodium (manufacturer unknown), meloxicam (manufacturer unknown), INVOKANA, Losartan/hydrochlorothiazide, clonazepam (manufacturer unknown), glimepiride (manufacturer unknown), NEXIUM, KOMBIGLYZE, amlodipine (manufacture unknown), LIPOFEN, CENTRUM and unspecified medication for high blood pressure. The patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: not reported) on 21 Sep 2015 at approximately 3 pm. On the same day of vaccination about 5 p.m. the patient experienced violent back/crippling pain in his back and he could barely walk or stand. It got progressively worse. The patient visited emergency room and physician identified 3 area of muscle in his back that were tense and gave him 3 injection. Outcome of the events was reported as condition unchanged. Outcome of the events was reported as condition unchanged. Seriousness of the events and causality were not reported.
Sex: U
Vaccine: FLUX, VARZOS
Symptoms: Influenza like illness, Injection site erythema
Clinical narrative: Case number PHHY2015US173702, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 597158) on 29 Dec 2015. This report refers to a patient of an unknown age and gender. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) along with ZOSTAVAX (batch number: not reported, other manufacturer) on an unknown date. On an unknown date after vaccination the patient experienced flu like symptoms and had a blood red injection site reaction. The outcome of the events was unknown. The case was assessed as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: DTAP, FLUX, PPV
Symptoms: Dysstasia, Feeling abnormal, Hypersomnia, Muscle spasms, Nausea
Clinical narrative: Case number PHHY2015US160502, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 597232) website on 24 Nov 2015. This report refers to a 43-year-old female patient. Historical condition included Sjogren's syndrome. Concomitant medications included PLAQUENIL, spironolactone and ZYRTEC. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) along with pneumococcal vaccine (manufacturer and batch number: not reported) and diphtheria, pertussis and polio vaccine (manufacturer and batch number: not reported) on 22 Sep 2015. On the same day after vaccination, the patient went to bed feeling bad and the patient woke up with nausea, fever, body cramps and the patient could not stand. The patient treatment included TYLENOL and ADVIL. The event body cramps lasted for 36 hours and fever continued for 48 hours. The patient slept down (bed rest) in the bed for 36 hours and missed two days of work. Final outcome of the events was recovered. Events were reported as non-serious. Causality was not reported.
Sex: F
Vaccine: DTAP, FLUX, PPV
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2015US160502, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 597232) website on 24 Nov 2015. This report refers to a 43-year-old female patient. Historical condition included Sjogren's syndrome. Concomitant medications included PLAQUENIL, spironolactone and ZYRTEC. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) along with pneumococcal vaccine (manufacturer and batch number: not reported) and diphtheria, pertussis and polio vaccine (manufacturer and batch number: not reported) on 22 Sep 2015. On the same day after vaccination, the patient went to bed feeling bad and the patient woke up with nausea, fever, body cramps and the patient could not stand. The patient treatment included TYLENOL and ADVIL. The event body cramps lasted for 36 hours and fever continued for 48 hours. The patient slept down (bed rest) in the bed for 36 hours and missed two days of work. Final outcome of the events was recovered. Events were reported as non-serious. Causality was not reported.
Age: 35.0
Sex: F
Vaccine: FLUX, HEPA
Symptoms: Activities of daily living impaired, Fatigue, Injection site discolouration, Injection site erythema, Injection site inflammation
Clinical narrative: Case number PHHY2015US156591, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 597413) website on 24 Nov 2015. This report refers to a 35 years old female patient. Historical conditions included psoriasis, asthma and psoriatic arthritis. Past vaccination history included influenza vaccine and the patient experienced (inflamed site, fever, fatigue, swollen arm, and entire, visibly swollen). Current conditions included pollen allergy, animals allergy, seafood allergy, feathers and fish allergy. Concomitant medication included: ENBREL, methotrexate (manufacturer unknown), NASACORT AQ, ASTELIN, SINGULAIR, tramadol (manufacturer unknown),nabumetone (manufacturer unknown), VIORELE, folic acid (manufacturer unknown), DULERA, DOVONEX, NIZORAL, melatonin (manufacturer unknown). The patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: not reported) in left arm subcutaneously and Hepatitis A vaccine in right arm subcutaneously both on 17 Sep 2015. On the same day after vaccination, the patient developed, injection site became inflamed and under the skin a knot could be felt. Injection site was inflamed, hot, and itchy. The patient had fever, fatigue and was experiencing an adverse reaction to certain smells (raw and cooked meat in particular). The size of the inflamed site grew until Tuesday 22 Sep 2015. The patient had miss her work on Monday 21 Sep 2015 because the patient felt so ill. As of 25 Sep 2015 when this report was being submitted, the knot was still visible and site still inflamed but now a dull purple instead of bright red. The final outcome of the events, seriousness and causality were not reported.
Age: 35.0
Sex: F
Vaccine: FLUX, HEPA
Symptoms: Injection site nodule, Injection site pruritus, Injection site warmth, Malaise, Parosmia
Clinical narrative: Case number PHHY2015US156591, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 597413) website on 24 Nov 2015. This report refers to a 35 years old female patient. Historical conditions included psoriasis, asthma and psoriatic arthritis. Past vaccination history included influenza vaccine and the patient experienced (inflamed site, fever, fatigue, swollen arm, and entire, visibly swollen). Current conditions included pollen allergy, animals allergy, seafood allergy, feathers and fish allergy. Concomitant medication included: ENBREL, methotrexate (manufacturer unknown), NASACORT AQ, ASTELIN, SINGULAIR, tramadol (manufacturer unknown),nabumetone (manufacturer unknown), VIORELE, folic acid (manufacturer unknown), DULERA, DOVONEX, NIZORAL, melatonin (manufacturer unknown). The patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: not reported) in left arm subcutaneously and Hepatitis A vaccine in right arm subcutaneously both on 17 Sep 2015. On the same day after vaccination, the patient developed, injection site became inflamed and under the skin a knot could be felt. Injection site was inflamed, hot, and itchy. The patient had fever, fatigue and was experiencing an adverse reaction to certain smells (raw and cooked meat in particular). The size of the inflamed site grew until Tuesday 22 Sep 2015. The patient had miss her work on Monday 21 Sep 2015 because the patient felt so ill. As of 25 Sep 2015 when this report was being submitted, the knot was still visible and site still inflamed but now a dull purple instead of bright red. The final outcome of the events, seriousness and causality were not reported.